No. |
DrugBank |
Drug (Description in trials) [Number of descriptions] |
KEGG DRUG * | KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 | Botulinum toxin type A | [3] Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Clostridium botulinum toxin type a; | D00783 |
[1] SNAP25 |
[2] Insulin secretion, Synaptic vesicle cycle |
[13] 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
2 | Davunetide | [2] Davunetide; Davunetide (al-108, nap); | D09401 |
- |
- |
[3] 5, 7, 127 |
3 | Dopamine | [9] Bromocriptine and other dopamine agonists; Cerebral dopamine neurotrophic factor; Continuous release dopamine agonists; Dopamine; Dopamine agent; Dopamine agonist treatment; Dopamine agonists; Dopamine agonists (pramipexole, ropirinole); Recombinant human cerebral dopamine neurotrophic factor; | D00633 D07870 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 |
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
[3] 6, 7, 74 |
4 | Flortaucipir F-18 | - | - |
- |
- |
[3] 5, 7, 127 |
5 | Flutemetamol | [2] Flutemetamol; Vizamyl (flutemetamol(f-18)); | - |
- |
- |
[5] 5, 6, 7, 17, 127 |
6 | L-Leucine | [1] L-leucine; | D00030 |
- |
- |
[7] 5, 6, 7, 127, 283, 284, 299 |
7 | Lithium carbonate | [1] Lithium carbonate; | D00801 |
- |
- |
[8] 2, 5, 7, 8, 13, 17, 19, 127 |
8 | Lithium citrate | - | D04749 |
- |
- |
[4] 2, 5, 7, 8 |
9 | Raclopride | [2] 11c-raclopride; Raclopride; | - |
- |
- |
[4] 5, 6, 7, 17 |